

Cover Story
Cancer History ProjectFree
By Otis W. Brawley and Paul Goldberg
In histories of oncology, Charles Gordon Zubrod is a name that flashes by quickly, someone who did something important a long time ago.
By Alexandria Carolan and Matthew Bin Han Ong
By Matthew Bin Han Ong
In Brief


Clinical Roundup
Drugs & Targets


Trending Stories
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers